Literature DB >> 19593734

Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine.

Elena Beltramo1, Elena Berrone, Sonia Tarallo, Massimo Porta.   

Abstract

BACKGROUND: Vascular cells in diabetes are subjected to daily fluctuations from high to low glucose. We aimed at investigating whether pulsed exposure to different glucose concentrations influences apoptosis in human retinal pericytes (HRP) versus bovine retinal pericytes (BRP), with consequences on the onset of diabetic retinopathy, and the possible protective role of thiamine.
METHODS: BRP and HRP (wild-type and immortalized) were grown in physiological/high glucose for 7 days, and then returned to physiological glucose for another 24, 48 or 72 h. Cells were also kept intermittently at 48-h intervals in high/normal glucose for 8 days, with/without thiamine/benfotiamine. Apoptosis was determined through ELISA, TUNEL, Bcl-2, Bax and p53 expression/concentration.
RESULTS: Continuous exposure to high glucose increased apoptosis in BRP, but not HRP. BRP apoptosis normalized within 24 h of physiological glucose re-entry, while HRP apoptosis increased within 24-48 h of re-entry. Intermittent exposure to high glucose increased apoptosis in HRP and BRP. Bcl-2/Bax results were consistent with DNA fragmentation, while p53 was unchanged. Thiamine and benfotiamine countered intermittent high glucose-induced apoptosis.
CONCLUSIONS: Human pericytes are less prone to apoptosis induced by persistently high glucose than bovine cells. However, while BRP recover after returning to physiological levels, HRP are more vulnerable to both downwardly fluctuating glucose levels and intermittent exposure. These findings reinforce the hypotheses that (1) glycaemic fluctuations play a role in the development of diabetic retinopathy and (2) species-specific models are needed. Thiamine and benfotiamine prevent human pericyte apoptosis, indicating this vitamin as an inexpensive approach to the prevention and/or treatment of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19593734     DOI: 10.1002/dmrr.996

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  9 in total

1.  Intermittent but not constant high glucose induces ER stress and inflammation in human retinal pericytes.

Authors:  Yimin Zhong; Joshua J Wang; Sarah X Zhang
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response.

Authors:  Rajesh Katare; Andrea Caporali; Costanza Emanueli; Paolo Madeddu
Journal:  J Mol Cell Cardiol       Date:  2010-06-08       Impact factor: 5.000

3.  Characterization of an Immortalized Human Microglial Cell Line as a Tool for the Study of Diabetic Retinopathy.

Authors:  Aurora Mazzeo; Massimo Porta; Elena Beltramo
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

4.  Effects of thiamine and fenofibrate on high glucose and hypoxia-induced damage in cell models of the inner blood-retinal barrier.

Authors:  Aurora Mazzeo; Chiara Gai; Marina Trento; Massimo Porta; Elena Beltramo
Journal:  Acta Diabetol       Date:  2020-07-12       Impact factor: 4.280

5.  The impact of thiamine treatment in the diabetes mellitus.

Authors:  Khanh Vinh Quoc Luong; Lan Thi Hoang Nguyen
Journal:  J Clin Med Res       Date:  2012-05-15

Review 6.  Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.

Authors:  Maha Coucha; Sally L Elshaer; Wael S Eldahshan; Barbara A Mysona; Azza B El-Remessy
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Apr-Jun

7.  Preventive effects of benfotiamine in chronic diabetic complications.

Authors:  Rana Chakrabarti; Megan Chen; Weihua Liu; Shali Chen
Journal:  J Diabetes Investig       Date:  2011-04-07       Impact factor: 4.232

8.  Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.

Authors:  Elena Beltramo; Aurora Mazzeo; Tatiana Lopatina; Marina Trento; Massimo Porta
Journal:  Diab Vasc Dis Res       Date:  2019-11-14       Impact factor: 3.291

9.  Thiamine and diabetes: back to the future?

Authors:  Elena Beltramo; Aurora Mazzeo; Massimo Porta
Journal:  Acta Diabetol       Date:  2021-06-05       Impact factor: 4.280

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.